Lionco Pharmaceutical Group Co (SHSE:603669) Asset Impairment Charge : ¥0.0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Lionco Pharmaceutical Group Co Asset Impairment Charge?

Lionco Pharmaceutical Group Co's Asset Impairment Charge for the three months ended in Mar. 2025 was ¥0.0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.0 Mil.

Lionco Pharmaceutical Group Co Asset Impairment Charge Historical Data

The historical data trend for Lionco Pharmaceutical Group Co's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lionco Pharmaceutical Group Co Asset Impairment Charge Chart

Lionco Pharmaceutical Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Asset Impairment Charge

Get a 7-Day Free Trial

Lionco Pharmaceutical Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Lionco Pharmaceutical Group Co Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

Lionco Pharmaceutical Group Co Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Lionco Pharmaceutical Group Co's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Lionco Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lionco Pharmaceutical Group Co Ltd (SHSE:603669) » Definitions » Asset Impairment Charge

Traded in Other Exchanges

N/A

Address

No. 20, National Highway 349, Naidong District, Shannan, CHN

Website

http://www.lingkang.com.cn

Lionco Pharmaceutical Group Co Ltd is engaged in the research and development of medicines. The product portfolio includes - Alanyl glutamine for injection, fructose for injection, inverted sugar for injection, xylitol for injection, riboflavin sodium phosphate for injection, and water-soluble vitamin for injection.

Executives

Zhang Jun Ke	Director
Wang Wen Nan	Director
Tao Xiao Gang	Director
Tao Ling Gang	Director
Tao Ling Ping	Director

Lionco Pharmaceutical Group Co Headlines

No Headlines